Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer

被引：0
|
作者：
Ji Hun Kang
Seung Soo Lee
Jin Hee Kim
Jae Ho Byun
Hyoung Jung Kim
Changhoon Yoo
Kyu-pyo Kim
Baek-Yeol Ryoo
Song Cheol Kim
机构：
[1] University of Ulsan College of Medicine,Department of Radiology and Research Institute of Radiology
[2] Asan Medical Center,Department of Radiology, Hanyang University College of Medicine
[3] Hanyang University Guri Hospital,Department of Oncology
[4] University of Ulsan College of Medicine,Department of Surgery
[5] Asan Medical Center,undefined
[6] University of Ulsan College of Medicine,undefined
[7] Asan Medical Center,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Pancreatic neoplasms; Magnetic resonance imaging; Chemotherapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：864 / 874
页数：10
相关论文
共 50 条
  • [31] The Role of MRI Pancreatic Protocol in Assessing Response to Neoadjuvant Therapy for Patients With Borderline Resectable Pancreatic Cancer
    Hussien, Nervana
    Hussien, Rasha S.
    Saad, Darine Helmy Amin
    El Kassas, Mohamed
    Elkhatib, Walid F.
    Ezz El Din, Mai
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [32] Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer
    Waugh, Evelyn
    Glinka, Juan
    Breadner, Daniel
    Liu, Rachel
    Tang, Ephraim
    Allen, Laura
    Welch, Stephen
    Leslie, Ken
    Skaro, Anton
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (02) : 229 - 237
  • [33] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma
    Kang, J.
    Kim, K-P.
    Yoo, C.
    Lee, J-L.
    Ryoo, B-Y.
    Chang, H-M.
    Lee, S. S.
    Park, D. H.
    Song, T. J.
    Seo, D. W.
    Lee, S. K.
    Kim, M-H.
    Hwang, D. W.
    Song, K. B.
    Lee, J. H.
    Kim, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [35] Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma
    Temraz, Sally
    Nassar, Farah
    Hammoud, Miza Salim
    Mukherji, Deborah
    O'Reilly, Eileen M.
    Dbouk, Haifa
    Farhat, Fadi
    Charafeddine, Maya
    Faraj, Walid
    Khalifeh, Mohammad J.
    Abou-Alfa, Ghassan K.
    Shamseddine, Ali
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 735 - 742
  • [36] Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy
    Kim, Kangpyo
    Park, Hee Chul
    Yu, Jeong Il
    Park, Joon Oh
    Hong, Jung Yong
    Lee, Kyu Taek
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Park, Joo Kyung
    Heo, Jin Seok
    Shin, Sang Hyun
    Min, Ji Hye
    Kim, Kyunga
    Han, In Woong
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 45
  • [37] Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX
    Hu, Hai-Jie
    Li, Fu-Yu
    ANNALS OF SURGERY, 2018, 268 (06) : E95 - E96
  • [38] Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
    Michelakos, Theodoros
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Deshpande, Vikram
    Wo, Jennifer Y.
    Ryan, David P.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Murphy, Janet E.
    Nipp, Ryan D.
    Parikh, Aparna
    Qadan, Motaz
    Warshaw, Andrew L.
    Hong, Theodore S.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    ANNALS OF SURGERY, 2019, 269 (04) : 733 - 740
  • [39] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [40] Neoadjuvant therapy in borderline resectable and resectable pancreatic cancer.
    Dhamija, Kriti
    Awuah, Kojo-Frimpong B.
    Marwaha, Alexander
    Kharoud, Harmeet
    Monga, Dulabh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 735 - 735
12345